Project Grant R01GM158941
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded New York University $333,076 on August 8, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to develop novel statistical methods, algorithms, and computational pipelines for analyzing omics data with complex heterogeneity. The project, spanning four years through July 31, 2029, addresses critical challenges in precision medicine by advancing unsupervised...
- Federal Project Grant Award Summary Rochester Institute of Technology received a $186,354 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2029. This award supports a comprehensive research initiative to elucidate the roles of protein glycosylation in prokaryotes through functional glycoproteomics. The research employs an interdisciplinary...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $436,361.00 under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year project (August 1, 2025 – July 31, 2030) focused on advancing protein structure determination methodologies. The Research Foundation for the State University of New York, serving as the fiscal agent for research conducted in Buffalo, will develop innovative computational algorithms and...
- Federal Project Grant Award Summary The Sloan-Kettering Institute for Cancer Research received a $528,000 Project Grant award dated April 15, 2026, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award funds fundamental research investigating histone glycation as a dynamic epigenetic mark, with work extending through January 31, 2031. The research focuses on understanding how non-enzymatic covalent...
- Federal Grant Award Summary The University of California, San Diego received a $347,086 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds a five-year research initiative focused on developing precision, functional glyconanoassemblies through supramolecular design. The research aims to advance synthetic glycan assembly...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Johns Hopkins University a $454,478 Project Grant (CFDA 93.859: Biomedical Research and Research Training) on September 10, 2025, to support research through August 31, 2030. The grant funds technology development to advance understanding of the glycan-protein interactome—the complex interactions between sugar structures (glycans) on cell surfaces and their protein binding partners. The research...
- Federal Grant Award Summary The University of California, Davis received a $402,051 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective February 26, 2026 through December 31, 2030. This award supports the development of an integrated platform for multi-glycomic characterization that automates the analysis of N- and O-glycans on cell membrane proteins and glycolipids. The research...
- Federal Project Grant Award Summary Arizona State University received a $413,036 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2027. The award supports the development of a novel single-molecule glycosaminoglycan (GAG) sequencing method using fluorophore-labeled lysosomal enzymes. Glycosaminoglycans are large, linear, sulfated...
- Summary of Federal Project Grant Award The National Institute of General Medical Sciences (NIGMS) awarded $866,250 to the University of California, Los Angeles on August 1, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) for a five-year project extending through May 31, 2030. This award supports a multidisciplinary research initiative investigating how genetic variants drive functional changes across molecular, cellular, and phenotypic levels. The research...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $125,000 to Columbia University's Health Sciences Division under the Biomedical Research and Research Training program (CFDA 93.859) on May 13, 2026, with completion targeted for April 30, 2028. This Project Grant supports research directed by a postdoctoral researcher in Dr. Anum Glasgow's laboratory to develop an integrated computational and experimental platform for decoding, modulating, and...
The National Institute of General Medical Sciences (NIGMS) awarded $343,007 in Project Grant funding on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a research initiative titled "Characterizing Glycosylation Regulatory Networks Using Single-Cell Multiomics and Mathematical Modeling." The Research Foundation for the State University of New York, serving as the fiscal agent, administers the award for research conducted in Buffalo, NY, with an ultimate completion date of March 31, 2030. This project will deliver integrated research products and outputs aimed at systematically characterizing how glycosylation—a critical post-translational modification affecting cellular function—is regulated in mammalian systems. The research team will generate single-cell multi-omics datasets (epigenomics, transcriptomics, and glycomics profiles) from hematopoietic stem cell differentiation studies, catalog transcriptional regulators of glycosylation genes through bioinformatics analysis, and develop both mechanistic and deep learning-based computational models to identify key regulatory networks governing glycan biosynthesis. These research outputs will advance fundamental understanding of glycosylation regulatory mechanisms and provide a foundation for future biomedical applications in disease diagnosis and treatment.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $343.0k | 5/26/26 |